Volitionrx Ownership
| VNRX Stock | USD 0.68 0.02 2.86% |
Shares in Circulation | First Issued 2004-09-30 | Previous Quarter 86.5 M | Current Value 96.5 M | Avarage Shares Outstanding 25.5 M | Quarterly Volatility 26.2 M |
Volitionrx | Build AI portfolio with Volitionrx Stock |
Volitionrx Stock Ownership Analysis
About 18.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.27. Volitionrx had not issued any dividends in recent years. VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company operates Nucleosomics a technology platform for blood test. Volitionrx operates under Diagnostics Research classification in the United States and is traded on AMEX Exchange. It employs 83 people. For more information please call the company at 646 650 1351 or visit https://www.volition.com.Volitionrx Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Volitionrx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Volitionrx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Volitionrx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Volitionrx Outstanding Bonds
Volitionrx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Volitionrx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Volitionrx bonds can be classified according to their maturity, which is the date when Volitionrx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| VW 375 13 MAY 30 Corp BondUS928668BF80 | View | |
| VW 475 13 NOV 28 Corp BondUS928668AU66 | View | |
| VW 4625 13 NOV 25 Corp BondUS928668AT93 | View | |
| VW 46 08 JUN 29 Corp BondUS928668BT84 | View | |
| US928668BL58 Corp BondUS928668BL58 | View | |
| VW 435 08 JUN 27 Corp BondUS928668BS02 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.